Videra Health

Videra Health provides an AI-powered platform that serves two primary markets: behavioral health providers and pharmaceutical/life sciences companies. The company positions itself as "The Human Understanding Company," focusing on multimodal AI analysis of video, voice, and text data to improve clinical outcomes and operational efficiency.

The platform analyzes patient interactions across multiple modalities to detect early warning signs of deterioration, suicide risk, and other clinical concerns. For behavioral health providers, Videra offers patient monitoring, automated follow-ups, and crisis detection tools. For life sciences companies, the platform provides clinical trial eCOA solutions, patient screening algorithms, and patient education tools designed to improve engagement and data quality in research settings.

The company reports specific operational outcomes including identifying over $3.2 million in revenue opportunities for one residential treatment facility, saving 31,600+ staff hours annually, and helping Behavioral Health Services North achieve a 64% reduction in crisis alerts. Videra serves notable clients including Discovery Behavioral Health, Kipu Health, and maintains a Bronze Partnership with The National Council for Mental Wellbeing.

Consider Videra Health when you need AI-driven patient monitoring that goes beyond traditional screening tools, particularly for behavioral health populations or CNS clinical trials. The platform's multimodal approach reportedly detects 3x more at-risk patients than single-modality assessments.

Organizations should expect a technology-driven engagement focused on reducing administrative burden while improving early intervention capabilities. The platform appears best suited for organizations ready to integrate AI monitoring into existing clinical workflows or research protocols, with emphasis on post-discharge engagement and continuous monitoring rather than point-in-time assessments.

Videra Health exclusively serves healthcare markets with deep specialization in behavioral health and addiction treatment settings. The platform addresses healthcare-specific challenges including suicide risk detection, crisis intervention, readmission prevention, and clinical documentation burden. For life sciences clients, the company focuses specifically on CNS therapeutic areas including movement disorders and neurological conditions.

The company maintains partnerships with behavioral health EHR vendors and holds Bronze Partnership status with The National Council for Mental Wellbeing, indicating active participation in the behavioral health provider community.

Mid-to-large behavioral health systems, residential treatment facilities, and addiction treatment centers with 50+ beds seeking to reduce readmissions and improve post-discharge outcomes. Also pharmaceutical companies running CNS trials who need richer endpoint data and real-time safety monitoring beyond what legacy eCOA platforms provide, particularly those willing to implement video-based assessments.